残留难治性脓胸腔的多学科重建管理:一项回顾性观察性队列研究
八例III期脓胸开窗术后成年患者接受胸壁重建并随访至少12个月,平均年龄56岁(范围22-76),其中六例有肿瘤病史、三例房颤、两例高血压;经强化感染控制与营养支持后于开窗术后中位11个月(范围5-51)行重建。七例随访无脓胸及支气管胸膜瘘复发,生活质量显著改善,ECOG体能状态从3改善至1;一例重建后56天死于心肺衰竭。
要点
- 八例患者开窗术后中位11个月(范围5-51)行游离组织重建,随访至少12个月。
- 七例随访无脓胸及支气管胸膜瘘复发,ECOG体能状态从3改善至1。
- 一例重建后56天死于心肺衰竭,需再入院。
核心结论
- 作者认为,包括多学科参与和各阶段优化在内的游离组织重建可成功闭合残留难治性脓胸腔且无复发,并带来生活质量的显著改善。
研究设计与样本
- 回顾性观察性队列研究,连续纳入八例开窗术后行胸壁重建的成年患者(年龄超过18岁),无排除标准,随访至少12个月。
主要发现
- 八例患者(六男两女),平均年龄56岁(范围22-76),均有合并症:肿瘤病史六例、心房颤动三例、高血压两例。
- 脓胸病因包括肺癌切除并发支气管胸膜瘘四例、肺炎两例、胸腔积液两例。
- 五例BMI偏低(范围16-22),营养不良通用筛查工具(MUST)评分中位2分(范围1-4)。
- 七例随访无脓胸及支气管胸膜瘘复发,均报告生活质量显著改善,ECOG体能状态从3改善至1。
- 一例重建后56天死于心肺衰竭,需再入院。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Patients with stage III empyema require chest wall fenestration to enable lung re-expansion and continuous drainage of the persisting empyema cavity. This chronic wound negatively affects patients' exercise tolerance, ability to carry out activities of daily living, and quality of life. METHODS: Eight consecutive patients underwent chest wall reconstruction following fenestration and were followed up over a minimum of 12 months. This study included adult patients (over 18 years of age). There were no exclusion criteria. Data were collected retrospectively. RESULTS: Eight patients (six male and two female), with a mean age of 56 years (range, 22-76), were included. All of them had comorbidities including history of neoplasia (n = 6), atrial fibrillation (n = 3), and hypertension (n = 2). Aetiology of empyema included lung cancer resection complicated by bronchopleural fistula (n = 4), pneumonia (n = 2), and pleural effusion (n = 2). Five patients had a low metabolic reserve evident by a low BMI (range, 16-22), and a median malnutrition universal screen tool (MUST) score of 2 (range, 1-4). Following intensive infection control and nutritional support, patients underwent reconstruction 11 months (median; range 5-51) after fenestration. Seven patients were followed up and had no recurrence of empyema and bronchopleural fistula. They all reported significant improvements in their quality of life, and their Eastern Cooperative Oncology Group (ECOG) performance status improved from three to one. One patient died 56 days post-reconstruction from cardiorespiratory failure, which required readmission to hospital. CONCLUSION: We demonstrate that free tissue reconstruction including multidisciplinary input and optimisation at all stages of care successfully closes residual recalcitrant empyema cavity without recurrence and leads to significant improvements in the quality of life.
引用
- Allen LC, Milton R, Bourke G, et al. Multidisciplinary reconstructive management of residual recalcitrant empyema cavity: A retrospective observational cohort study. J Plast Reconstr Aesthet Surg. 2021. PMID: 34872875. doi:10.1016/j.bjps.2021.09.073
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。